Aegicare
Palo Alto
About Aegicare
Aegicare develops gene intelligence algorithms for patients, medical institutions, scientific research institutions, and pharmaceutical companies. That provides sample management, bioinformatics analysis, a family map, and information retrieval. Aegicar uses genetic intelligence to diagnose rare diseases and develop drugs. Aegicar Aegicar develops gene intelligence algorithms for patients, medical institutions, scientific research institutions, and innovative pharmaceutical companies based on cutting-edge bioinformatics, medical genetics, high-throughput sequencing technology, functional genomics technology, artificial intelligence, and cloud computing technology to solve rare disease-related information mining, translation, interpretation, clinical decision-making assistance, and drug development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $7.8M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2019)
- Website: aegicare.com
Industries & Categories
Artificial Intelligence (AI), Genetics, Medical, Pharmaceutical, Precision Medicine
Social Profiles
Canonical: https://fsome.com/organization/aegicare-17922 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.